This study shows that ZMapp, an optimized cocktail of three monoclonal antibodies that has been pressed into clinical use in response to the current Ebola virus disease epidemic, was able to rescue all of 18 rhesus macaques when treatment was initiated up to five days post-infection. All three controls had died by day eight.
- Ebola therapy protects severely ill monkeys (News & Views p41, doi: 10.1038/nature13746)
- Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp (Article p47, doi: 10.1038/nature13777)
Recent Hot Topics
Sign up for Nature Research e-alerts to get the lastest research in your inbox every week.